LEP and fatty liver disease: After full adjustment for ATP III metabolic syndrome components, age, sex, and BMI, leptin deficiency remained inversely associated with MASLD (RRR 0.48, 95% CI 0.27–0.86, p = 0.014), indicating that individuals classified as having constitutively low leptin levels showed reduced hepatic steatosis independent of overall metabolic health.